Moderna Considers to Include Children Aged 5-11 in the COVID-19 Vaccine Clinical Trials

Moderna is looking to include children aged five to 11 years to its coronavirus vaccine trials after reports of rare heart problems. The company said it is working with the Food and Drug Administration on how to handle the details.